ImportRefusal LogoImportRefusal

OBER CONSULTING POLAND SP. Z O.O

⚠️ Moderate Risk

FEI: 3013325496 • Poznan, Wielkopolskie • POLAND

FEI

FEI Number

3013325496

📍

Location

Poznan, Wielkopolskie

🇵🇱

Country

POLAND
🏢

Address

Brzechwy 6 60-195 Pozna, , Poznan, Wielkopolskie, Poland

Moderate Risk

FDA Import Risk Assessment

30.8
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
6
Unique Violations
6/8/2015
Latest Refusal
6/3/2015
Earliest Refusal

Score Breakdown

Violation Severity
52.7×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3412×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

4762×

NO REGISTR

The article appears to be an electronic product that does not comply with an applicable standard as prescribed by Section 534 because no reporting has been provided as required by Section 537(b).

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

30811×

INVDEVICE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a device for investigational use for which no exemption has been granted as prescribed by Section 520(g)

Refusal History

DateProductViolationsDivision
6/8/2015
86HMCMONITOR, EYE MOVEMENT, DIAGNOSTIC
118NOT LISTED
237NO PMA
3280FRNMFGREG
341REGISTERED
Cincinnati District Office (CIN-DO)
6/4/2015
86HQFLASER, OPHTHALMIC
118NOT LISTED
3081INVDEVICE
3280FRNMFGREG
476NO REGISTR
Cincinnati District Office (CIN-DO)
6/3/2015
86HLLMONITOR, EYE MOVEMENT
118NOT LISTED
341REGISTERED
476NO REGISTR
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is OBER CONSULTING POLAND SP. Z O.O's FDA import refusal history?

OBER CONSULTING POLAND SP. Z O.O (FEI: 3013325496) has 3 FDA import refusal record(s) in our database, spanning from 6/3/2015 to 6/8/2015.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. OBER CONSULTING POLAND SP. Z O.O's FEI number is 3013325496.

What types of violations has OBER CONSULTING POLAND SP. Z O.O received?

OBER CONSULTING POLAND SP. Z O.O has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about OBER CONSULTING POLAND SP. Z O.O come from?

All FDA import refusal data for OBER CONSULTING POLAND SP. Z O.O is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.